These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 662176

  • 21. [Granulocyte adherence in advanced Hodgkin's disease and its dependence on antiproliferative drugs used].
    Hansz J, Prazmowska-Owczarek B, Nowicka G.
    Acta Haematol Pol; 1979; 10(1):7-12. PubMed ID: 373364
    [Abstract] [Full Text] [Related]

  • 22. Bone marrow neutrophil granulocyte reserve in patients undergoing intermittent hemodialysis.
    Lusvarghi E, Zirilli E, Gaiani G, Bonucchi D, Zagni G, Davoli D.
    Haematologica; 1985; 70(5):396-8. PubMed ID: 3937774
    [No Abstract] [Full Text] [Related]

  • 23. Defect of bone marrow granulocyte reserve in viral hepatitis.
    Magliulo E, Gallina M, Scevola D, Concia E.
    Acta Haematol; 1975; 54(1):27-31. PubMed ID: 808075
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Clinical aspects and therapy of stage III Hodgkin's disease (author's transl)].
    Weh HJ, Andrieu JM.
    MMW Munch Med Wochenschr; 1980 Jun 20; 122(25):932-4. PubMed ID: 6772941
    [Abstract] [Full Text] [Related]

  • 26. Clinical trials with intensive chemotherapy and radiotherapy in Hodgkin's disease.
    De Lena M, Monfardini S, Beretta G, Fossati-Bellani F, Bonadonna G.
    Natl Cancer Inst Monogr; 1973 May 20; 36():403-20. PubMed ID: 4126720
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Evaluation of polychemotherapy and its complications in late stages of Hodgkin's disease].
    Anikin BS, Kaganov AL, Tarlova RM.
    Ter Arkh; 1976 May 20; 48(8):73-9. PubMed ID: 1024302
    [No Abstract] [Full Text] [Related]

  • 29. Effects of etiocholanolone and prednisolone on intravascular granulocyte kinetics in horses.
    Carakostas MC, Moore WE, Smith JE, Johnson D.
    Am J Vet Res; 1981 Apr 20; 42(4):626-8. PubMed ID: 7332123
    [Abstract] [Full Text] [Related]

  • 30. [Clinico-pathological characteristics, response to therapy and survival of patients with bone marrow infiltration by Hodgkin's lymphoma].
    Marisavljević D, Bosković D, Petrović M, Colović M, Radosević-Radojković N, Jovanovitsh V.
    Srp Arh Celok Lek; 1995 Apr 20; 123(3-4):68-72. PubMed ID: 16296226
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Effect of splenectomy on hematological tolerance and the results of chemotherapy in Hodgkin's disease].
    Robak T, Płuzańska A, Dmochowska M, Krykowski E, Oliskiewicz W, Fajndt S, Maciejczyk J, Jabłkowski W, Mazurowa A.
    Acta Haematol Pol; 1982 Apr 20; 13(1-2):5-11. PubMed ID: 7180356
    [No Abstract] [Full Text] [Related]

  • 33. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 20; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 34. Defect of bone marrow granulocyte reserve in liver cirrhosis evaluated with etiocholanolone.
    Cambiaghi G, Paina S.
    Acta Haematol; 1978 Dec 20; 60(5):291-5. PubMed ID: 101015
    [Abstract] [Full Text] [Related]

  • 35. [The bone marrow in Hodgkin's disease following radiotherapy and splenectomy].
    Baĭsogolov GD, Pavlov VV, Bogatyreva TI, Khait SE, Kuz'mina EG.
    Med Radiol (Mosk); 1987 May 20; 32(5):3-7. PubMed ID: 3586920
    [Abstract] [Full Text] [Related]

  • 36. [Research on the prognostic value of immunodeficiency in Hodgkin's disease].
    Szász B, Dudea C, Róna L, Kifor I, Borsai G, Zegrean G, Rad L.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980 May 20; 32(6):511-20. PubMed ID: 6113670
    [No Abstract] [Full Text] [Related]

  • 37. [Tissue migration of neutrophil granulocytes in the course of antiproliferative treatment in Hodgkin's disease].
    Wysocki H, Wierusz-Wysocka B, Prazmowska-Owczarek B, Hansz J.
    Acta Haematol Pol; 1976 May 20; 7(2):117-22. PubMed ID: 936962
    [Abstract] [Full Text] [Related]

  • 38. [Cyclic polychemotherapy of Hodgkin's disease].
    Berényi E, Szegedi G.
    Orv Hetil; 1984 Oct 07; 125(41):2477-81. PubMed ID: 6493760
    [No Abstract] [Full Text] [Related]

  • 39. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
    Eghbali H, Pétorin C, de Mascarel I, Trojani M, Hoerni-Simon G, Soubeyran P, Hoerni B.
    Bull Cancer; 1994 Oct 07; 81(10):866-70. PubMed ID: 7734769
    [Abstract] [Full Text] [Related]

  • 40. The role of high-dose therapy and autologous bone marrow reinfusion in the treatment of Hodgkin's disease.
    Williams SF, Bitran JD.
    Hematol Oncol Clin North Am; 1989 Jun 07; 3(2):319-30. PubMed ID: 2663830
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.